Oncura's goal is to ensure that all cancer patients should have access to the minimally invasive benefits of brachytherapy when it is a suitable clinical option.
To achieve this we have invested heavily in delivering world class training and education to healthcare professionals, in addition to raising public awareness and access to brachytherapy for prostate cancer treatment.
***ONCURA™ Announces Exclusive Supply and Resale Agreement with Theragenics Corporation***
ONCURA™ and Theragenics Corporation Announce Distribution Agreement
Includes information about each product and the availability of brochures, technical data and clinical papers.